Circulating Microparticles Reflect Treatment Effects and Clinical Status in Multiple Sclerosis

References

• Lai CP-K , BreakefieldXO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies.Front. Physio.3, 228 (2012).
   PubMed Web of Science ®Google Scholar
• Waldenström A , GennebäckN, HellmanUet al. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE 7 (4), e34653 (2012).
   PubMed Web of Science ®Google Scholar
• Théry C , OstrowskiM, SeguraE. Membrane vesicles as conveyors of immune responses.Nat. Rev. Immunol.9, 581 – 593 (2009).
   PubMed Web of Science ®Google Scholar
• Verderio C , MuzioL, TurolaEet al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 72, 610 – 624 (2012).
   PubMed Web of Science ®Google Scholar
• Pisetsky DS , UllalAJ, GauleyJet al. Microparticles as mediators and biomarkers of rheumatic disease. Rheumatology (Oxford) 51 (10), 1737 – 1746 (2012).
   PubMed Web of Science ®Google Scholar
• Sellam J , ProulleV, JüngelAet al. Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res. Ther. 11 (5), R156 (2009).
   PubMed Web of Science ®Google Scholar
• Sadovnick A . European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender.J. Neurol. Sci.286 (1–2), 1 – 5 (2009).
   PubMed Web of Science ®Google Scholar
• Roxburgh RH , SeamanSR, MastermanTet al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64 (7), 1144 – 1151 (2005).
   PubMed Web of Science ®Google Scholar
• Sheremata WA , JyW, DelgadoSet al. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J. Neuroinflammation. 3, 23 (2006).
   PubMed Web of Science ®Google Scholar
• Lowery-Nordberg M , EatonE, Gonzalez-ToledoEet al. The effects of high dose interferon-β1a on plasma microparticles: correlation with MRI parameters. J. Neuroinflammation. 8, 43 (2011).
   PubMed Web of Science ®Google Scholar
• Sheremata W , JyW, HorstmanLet al. Evidence of platelet activation in multiple sclerosis. J. Neuroinflammation. 5, 27 (2008).
   PubMed Web of Science ®Google Scholar
• Minagar A , JyW, JimenezJJet al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56 (10), 1319 – 1324 (2001).
   PubMed Web of Science ®Google Scholar
• Robert S , PonceletP, LacroixRet al. Standardization of platelet derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J. Thromb. Haemost. 7, 190 – 197 (2008).
   PubMed Web of Science ®Google Scholar
• Jy W , MinagarA, JimenezJJet al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front. Biosci. 9, 3137 – 3144 (2004).
   PubMed Web of Science ®Google Scholar
• Barry OP , PraticòD, SavaniRCet al. Modulation of monocyte–endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102 (1), 136 – 144 (1998).
   PubMed Web of Science ®Google Scholar
• Andreola G , RivoltiniL, CastelliCet al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195 (10), 1303 – 1316 (2002).
   PubMed Web of Science ®Google Scholar
• Sarkar A , MitraS, MehtaSet al. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS ONE 4 (9), e7140 (2009).
   PubMed Web of Science ®Google Scholar
• Dutta R , TrappBD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Prog. Neurobiol.93 (1), 1 – 12 (2011).
   PubMed Web of Science ®Google Scholar
• Planas R , JelčićI, SchipplingSet al. Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis. Eur. J. Immunol. 42 (3), 790 – 798 (2012).
   PubMed Web of Science ®Google Scholar
• Jimenez J , JyW, MauroLMet al. Horstman LL. Elevated endothelial microparticle–monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte–endothelial microparticle complexes. Mult. Scler. 11 (3), 310 – 315 (2005).
   PubMed Web of Science ®Google Scholar
• Irizar H , Muñoz-CullaM, ZurriaríanOet al. HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult. Scler. 18 (5), 569 – 577 (2012).
   PubMed Web of Science ®Google Scholar
• Madden LA , VinceRV, SandströmMEet al. Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects. Thromb. Haemost. 99 (5), 909 – 915 (2008).
   PubMed Web of Science ®Google Scholar
• Bastos-Amador P , RoyoF, GonzalezEet al. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J. Proteomics. 75 (12), 3574 – 3584 (2012).
   PubMed Web of Science ®Google Scholar